Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

pan-CLK inhibitor

DRUG CLASS:

pan-CLK inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

CTNNB1 mutation	Endometrial Cancer	CTNNB1 mutation	Endometrial Cancer	PRI724 + SM04690 Sensitive: B - Late Trials PRI724 + SM04690 Sensitive : B	PRI724 + SM04690 Sensitive: B - Late Trials PRI724 + SM04690 Sensitive : B
CTNNB1 mutation	Endometrial Cancer	CTNNB1 mutation	Endometrial Cancer	SM04690 Sensitive: B - Late Trials SM04690 Sensitive : B	SM04690 Sensitive: B - Late Trials SM04690 Sensitive : B
FLT3-ITD mutation	Acute Myelogenous Leukemia	FLT3-ITD mutation	Acute Myelogenous Leukemia	venetoclax + SM09419 Sensitive: D – Preclinical venetoclax + SM09419 Sensitive : D	venetoclax + SM09419 Sensitive: D – Preclinical venetoclax + SM09419 Sensitive : D
FLT3-ITD mutation	Acute Myelogenous Leukemia	FLT3-ITD mutation	Acute Myelogenous Leukemia	midostaurin + SM09419 Sensitive: D – Preclinical midostaurin + SM09419 Sensitive : D	midostaurin + SM09419 Sensitive: D – Preclinical midostaurin + SM09419 Sensitive : D
HR positive	Hormone Receptor Positive Breast Cancer	HR positive	Hormone Receptor Positive Breast Cancer	SM08502 Sensitive: D – Preclinical SM08502 Sensitive : D	SM08502 Sensitive: D – Preclinical SM08502 Sensitive : D
TP53 mutation	Acute Myelogenous Leukemia	TP53 mutation	Acute Myelogenous Leukemia	venetoclax + SM09419 Sensitive: D – Preclinical venetoclax + SM09419 Sensitive : D	venetoclax + SM09419 Sensitive: D – Preclinical venetoclax + SM09419 Sensitive : D
TP53 mutation	Acute Myelogenous Leukemia	TP53 mutation	Acute Myelogenous Leukemia	SM09419 Sensitive: D – Preclinical SM09419 Sensitive : D	SM09419 Sensitive: D – Preclinical SM09419 Sensitive : D
FLT3-ITD mutation	Acute Myelogenous Leukemia	FLT3-ITD mutation	Acute Myelogenous Leukemia	SM09419 Sensitive: D – Preclinical SM09419 Sensitive : D	SM09419 Sensitive: D – Preclinical SM09419 Sensitive : D
SRSF2 P95L	Myelodysplastic Syndrome	SRSF2 P95L	Myelodysplastic Syndrome	CTX-712 Sensitive: D – Preclinical CTX-712 Sensitive : D	CTX-712 Sensitive: D – Preclinical CTX-712 Sensitive : D
SRSF2 P95L	Acute Myelogenous Leukemia	SRSF2 P95L	Acute Myelogenous Leukemia	CTX-712 Sensitive: D – Preclinical CTX-712 Sensitive : D	CTX-712 Sensitive: D – Preclinical CTX-712 Sensitive : D
SRSF2 P95H	Myelodysplastic Syndrome	SRSF2 P95H	Myelodysplastic Syndrome	CTX-712 Sensitive: D – Preclinical CTX-712 Sensitive : D	CTX-712 Sensitive: D – Preclinical CTX-712 Sensitive : D